Allergic Rhinitis and Rhinoconjunctivitis
HAL Allergy B.V. focuses on moderate to severe allergic rhinitis and rhinoconjunctivitis linked to house dust mite sensitisation, including persistent nasal and ocular allergy symptoms in adults.
- Allergic rhinitis
- Rhinoconjunctivitis
- House dust mite allergy
The sponsor’s clinical interest is centred on allergy-driven upper airway disease and symptom control in affected adult populations.
Asthma Associated with Allergen Sensitisation
The company also studies asthma occurring alongside house dust mite-induced respiratory allergy, reflecting interest in patients with overlapping upper and lower airway involvement.
- Asthma
- Allergen-induced respiratory disease
- Combined airway allergy
This area includes clinical attention to respiratory symptoms that accompany perennial allergen exposure.
Subcutaneous Immunotherapy
HAL Allergy B.V. has a clear therapeutic focus on subcutaneous immunotherapy for house dust mite allergy, with work centred on allergy desensitisation in adults with clinically significant symptoms.
- Subcutaneous immunotherapy
- Allergen immunotherapy
- HDM-directed treatment
Its research activity in this field is directed toward therapeutic options for chronic allergic disease management.
Respiratory Allergy in Multicentre Clinical Settings
The sponsor is involved in clinical research on respiratory allergy across multiple European sites, supporting evaluation in diverse adult populations with perennial allergen exposure.
- Respiratory allergy
- Perennial allergen exposure
- Adult allergy care
This research domain reflects therapeutic interest in real-world allergic disease patterns across several countries.
